No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition Corp. - Units trades on the stock market under the symbol DMAAU.
As of August 28, 2026, DMAAU stock price was flat at $10.83 with million shares trading.
DMAAU has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMAAU has underperformed the market in the last year with a return of +2.2%, while the SPY ETF gained +20.1%. In the last 3 month period, DMAAU fell short of the market, returning +0.8%, while SPY returned +2.8%. However, in the most recent 2 weeks DMAAU has outperformed the stock market by returning +0.4%, while SPY returned -1.1%.
DMAAU support price is $10.80 and resistance is $10.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMAAU shares will trade within this expected range on the day.
